Curriculum Vitae

Blood Products Advisory Committee

Mark Ballow, M.D.

Birthdate:	----------------------------
Birthplace:	-----------------------------
Office Address:	Chief, Division of Allergy/Immunology Department of Pediatrics The Children's Hospital of Buffalo 219 Bryant Street Buffalo, NY 14222 --------------------------- ------------------------
Home Address:	------------------------------------ ---------------------------------- ---------------------------------- ----------------------------------------------------------- ----------------------------------------------------------- -----------------------------------------------------------
Undergraduate Education:	Rutgers University, Department of Biological Sciences, New Brunswick, NJ; BA, June, ---- University of Chicago, School of Medicine; M.D., ----
Postgraduate Training:	Intern, Department of Pediatrics, Yale-New Haven Hospital, 7/69-7/70 Resident, Department of Pediatrics, Yale-New Haven Hospital, 7/70-7/71 Medical Fellow, Department of Pediatrics, University of Minnesota Hospitals, 7/71-7/73
Professional Experience:	Chief, Clinical and Experimental Immunology, Walter Reed Army Medical Center, Washington, DC; 7/73-7/75 Assistant Professor, Department of Pediatrics, The University of Connecticut Health Center, 7/75-10/79 Associate Professor, Department of Pediatrics, The University of Connecticut Health Center, 10/79-10/85 Professor, Department of Pediatrics The University of Connecticut Health Center, 10/85-7/88 Professor, Department of Pediatrics State University of New York at Buffalo, School of Medicine and Biomedical Sciences Chief, Division of Allergy/Immunology, and Pediatric Rheumatology Children's Hospital of Buffalo, 7/88 - present Medical Director of the Clinical Laboratories at Children's Hospital of Buffalo, 1992- to present.
Academic and Professional Honors:	Phi Beta Kappa, ----, Rutgers University Henry Rutgers Scholar Alpha Omega Alpha Medical Honor Society Borden Undergraduate Research Award in Medicine Graduation with Honors, University of Chicago School of Medicine The Carl E. Arbesman Memorial Lectureship, American Academy of Allergy and Immunology, March 5, 1994 The John C Selner Lecturer, American College of Allergy, Asthma, & Immunology, Nov. 7,2000
Membership:	Phi Beta Kappa, 1965 Rutgers University Alpha Omega Alpha Medical Honor Society
Board Certifications:	National Board of Medical Examiners, 1971 Diplomate, American Board of Pediatrics, April, 1974 Diplomate, American Board of Allergy and Immunology, October, 1975 Diplomate, Clinical Laboratory Immunology, October 1988
Licensure:	Connecticut, State Board of Medical Examiners, No. -----, Oct. 28,1970 Maryland, State Board of Medical Examiners, No. ------, Nov. 29, 1973 New York, State Board of Medical Examiners, No. -------, May 23, 1988
National Societies:	Society for Pediatric Research American Pediatric Society Buffalo Allergy Society Clinical Immunology Society American Academy of Allergy and Immunology
National Offices in Societies:	Executive Committee, Training Program Directors in Allergy & Immunology, American Academy of Allergy, Asthma and Immunology, 1992-present. Chair, Training Program Directors Committee, American Academy of Allergy, Asthma and Immunology 1996-1998 Director, American Board of Allergy and Immunology, a Conjoint Board of the American Board of Internal Medicine and the American Board of Pediatrics (6 year term; 1/1/93-12/98); Treasurer- 1997-1998. Chair, Basic and Clinical Immunology Interest Section, American Academy of Allergy and Immunology, 1997-1999. Board of Directors, American Academy of Allergy, Asthma and Immunology (AAAAI), 1996-1999 Chair, TPD-RRC Subcommittee of the Training Programs Director Committee of the AAAAI, 2000-2003 Chair, Chrysalis Committee for the AAAAI, 2001-2006 Chair, Committee on Primary Care Rotations in Allergy for the AAAAI, 2000-2004 Chair, Immuno-ophthalmology interest section committee for the AAAAI, 2001-2003 Board of Directors, Clinical Immunology Society, 1997-2000. Secretary-Treasurer, Clinical Immunology Society, 1999-2007
Ad. hoc Journal Reviewer:	New England Journal of Medicine Journal of Pediatrics Pediatrics Journal of Allergy and Clinical Immunology Clinical Immunology Pediatric Research Journal of Clinical Immunology
Editorial Boards:	Journal of Allergy and Clinical Immunology, 1984-1989, 1995-2000 Infections in Medicine, 1991 to present Journal of Clinical Immunology, 1993-1996 Pediatric Asthma, Allergy and Immunology, 1996-present Clinical Reviews in Allergy & Immunology, 1992-present Journal of Investigational Allergy & Clinical Immunology 2000-03
Editor, Journals:	Co-editor for Current Opinion in Allergy and Clinical Immunology, Lippincott Williams & Wilkins, 2000 - E-Medicine, Editor for Pediatric Allergy & Immunology section, 2000 -
Peer Review Study Sections:	Clinical Sciences, University of Connecticut Research Foundation, 1977-1980 Special N.I.H. Study Section on AIDS Vision Science A Special Study Section of Eye Institute Ad hoc reviewer for March of Dimes Ad hoc reviewer, Small Business Grants- NIH study section Ad hoc reviewer, special AIDS study section (1989,1991)
Sabbatical:	July 1985-July 1986. Metabolism Branch, NCI at NIH Lab of Drs. M Blaese & S. Korsmeyer. "Molecular biology of Immunoglobulin gene recombinatorial events"
Special Committees:	Medical Knowledge Self-Assessment Program (MKSAP) in Allergy and Immunology, American College of Physicians, Philadelphia, PA, (Chairpersons: J Fink and RF Lockey), 1991- 1993. Chair, Postgraduate Education, American Academy of Allergy and Immunology, 1994. Strategic Planning Subcommittee, The Theodore T. Jacobs, MD Institute of Molecular Medicine and Immunology, 1994-1996 Professional Staff, Ernest Witebsky Center Committee, School of Medicine and Biolmedical Sciences, SUNYAB, July 1994-June 1998. Medical Knowledge Self-Assessment Program (MKSAP) in Allergy and Immunology, 2000-2003

Bibliography

Articles:

Blough, H.A.; Ballow, M. and Kreider, J.: A sandwich technique for the detection myxovirus infected cells using a fluorescein conjugated antibody directed against a glycoprotein substratefectuin. J. Immunol. 100:209-213, 1968.
Ballow, M. and Cochrane, C.G.: Two anticomplementary factors in cobra venom: Hemolysis of guinea pig erythrocytes by one of them. J. Immunol. 103:944-952, 1969.
Ballow, M.: Margolis, C.; Schactel, B. and Hsia, Y.E.: Progressive familial intrahepatic cholestasis. Peds. 51:998-1007, 1973.
Ballow, M.; Day, N.K.B. and Good, R.A.: Effect of cobra venom factor on the local GVH reaction. I. Partial characterization of a cytotoxic factor from cobra venom for rat lymphocytes. J. Immunol. 110:354-361, 1973.
Gatti, R.A.; Robinson, W.A.; Deinard, A.S.; Nesbit, M.; McCullough, J.J.; Ballow, M. and Good, R.A.: Cyclic leukocytosis in chronic myelogenous leukemia: New perspectives on pathogenesis and therapy. Blood 41:771-782, 1973.
Ballow, M.; Dupont, B. and Good R.A.: Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with a transfer factor. J. Peds. 83:772-780, 1973.
Ballow, M.; Day, N.K. and Good, R.A.: Depletion of complement during graft-versus-host reaction in a severe combined immunodeficiency patient after receiving a mismatched marrow transplant. Transplan. 16:380-382, 1973.
Gajl-Peczalska, K.J.; Ballow, M.; Hansen, J.A.; Good, R.A.: IgE-bearing lymphocytes and atopy in a patient with X-linked infantile agammaglobulinemia. Lancet 1:1254. 1973.
Ballow, M.; Day, N.K.; Biggar, W.D.; Park, B.H. and Good, R.A.: Reconstitution of serum Clq following bone marrow transplantation in patients with severe combined immunodeficiency disease. Clin. Immunol. Immunopathol. 2:28-35, 1973.
Dupont, B.; Ballow, M.; Hansen, J.A.; Quick, C.; Yunis, E.J. and Good, R.A.: Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc. Nat. Acad. Sci. 71:867-871, 1974.
Ballow, M.; Park, B.H.; Dupont, B.; Cadwell, R.R.; Lonsdale, D. and Good, R.A.: Benign giant lymphoid hyperplasia of the mediastinum with associated abnormalities of the immune system. J. Peds. 34:418-420, 1974.
Ballow, M.; Fang, F.; Good, R.A. and Day, N.K.: Developmental aspects of complement components in the newborn and the presence of complement components and C3 proactivator (Properdin Factor B) in human colostrum. Clin. Exp. Immunol. 18:257-266, 1974.
Ballow, M.; Day, N.K. and Good, R.A.: Complement in graft-versus-host disease. I. Depletion of complement components during a systemic graft-versus-host reaction in the rat. Soc. for Exp Biol and Medicine 148:170-176, 1975.
Ballow, M.; Shira, J.E.; Harden, L.; Yank, S.Y. and Day, N.K.: Complete absence of the third component of complement in man. J. Clin. Invest. 56:703-710, 1975.
Ballow, M.; Ward, G.W., Jr.; Gershwin, M.E. and Day, N.K.: Cl-bypass complement activation pathway in patients with idiopathic chronic urticaria and angioedema. Lancet 2 248:250, 1975.
Ballow, M. and Good, R.A.: Report of a patient with T-cell deficiency and normal B-cell function: A new immunodeficiency disease with response to transfer factor. Cell. Immuno. 19:219-229, 1975.
Ballow, M. and Hyman, L.: Combination immunotherapy in chronic mucocutaneous candidiasis: Synergism between transfer factor and fetal thymus tissue. Clin. Immunol. Immunopathol. 8:504-512, 1977.
Hyman, L.; Ballow, M. and Kneiser, M.: Diphenylhydantoin-induced interstitial nephritis: Roles of Cellular and humoral immunologic injury. J. Peds. 92 (6):915-920, 1978.
Einstein, L.P.; Hansen, P.J.; Ballow, M.; Davis, A.E.; Davis J. S.; Alper, C.A.; Rosen, F.S. and Colten, H.R.: Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3 deficient humans. J. Clin. Invest. 60:963-969, 1977.
Lundy, J.; Damjanov, I.; Ballow, M.; Henken, M. and Mitchell, M.S.: Pulmonary granulomas in a patient on MER therapy. The Yale J. Biol. and Med. 50 (6):665-668, 1977.
Ballow, M.: Modulation of mixed-lymphocyte-culture reactivity following alloimmunization between H-1 (Ag-B) histocompatible rat strains. Transplan. 26:295-299, 1978.
Ballow, M.; McLean, R.H.; Damjanov, I. and Lowenstein, M.B.: Immunologic reconstitution, autoimmunity and T-cell deficiencies. Cell. Immuno., 45:364-376, 1979.
Ballow, M. and Rickles, F.R.: Impaired monuclear cell tissue factor generation in patients with severe combined immuno deficiency. Blood, 56:402-408, 1980.
Ballow, M.: Modulations of immunoglobulin synthesis in vitro by dialyzable transfer factor in proceedings of the third international symposium on transfer factor (N.O. Hill, A. Khan and C. Kirpatrick, eds.) Academic Press: New York, 1979, pp. 461-467.
O'Neill, G.J.; Berger, R.; Ballow, M.; Yunis, E.J. and Dupont, B.: Chido and Rodgers blood groups and C4 deficiency. Transplan Proceed 11:1941-1943, 1979.
Ballow, M.; McLean, R.H.; Einarson, M.; Martin, S.; Yunis, E.J.; Dupont, B. and O'Neill, G.J.: Hereditary C4 deficiency - genetic studies and linkage to HLA. Transplan. Proceed 11:1710-1712, 1979.
Ballow, M. and Mendelson, L.: Specific IgE antibodies in the tear secretions of patients with vernal conjunctivitis. J Allergy Clin Immunol 66(2):112-118, 1980.
Ballow, M.: Autoimmune hemolytic anemia and immune regulation. Amer J Ped Hem Onc 2:173-180, 1980.
Sanders, W.M.; Zimmerman, A.W.; Mahoney, M.A. and Ballow, M.: Leukocyte histamine release in migraine. Headache 20:307-310, l980.
Ballow, M. and Pantschenko, A.: In vitro effects of ADA inhibitors on lymphocyte mitogen responsiveness in the mouse. Cell Immunol 64:290-43, 1981.
Ballow, M.; McLean, R.H.; Yunis, E.J.; Awdeh, Z.L.; O'Neill, G.J.; Einarson, M.; Alper, C.A.: C4 polymorphism and HLA linkage: Studies in a family with hereditary C4 deficiency. Clin Immunol Immunopathol 20:354-360, 1981.
Awdeh, Z.L.; Raum, D.D.; Glass, D.; Agnello, V.; Schur, P.H.; Johnson, R.B., Jr.; Gelfand, E.W.; Ballow, M.; Yunis, E. and Alper, C.A.: Complement-Human histocompatibility antigen haplotyes in C2 deficiency. J Clin Invest 67:581-583, 1981.
Eisenberg, E.; Ballow, M.; Wolfe, S.H.; Krutchkoff, D.J.; Tanzer, J.M.: Pemphigus-like mucosal lesions: a side effect of penicillamine therapy. Oral Surg, Oral Med, Oral Patho 51:409-414, 1981.
Ballow, M.; Kennedy, T.L.; Gaudio, K.M.; Siegel, N.J.; McLean, R.H.: Serum hemolytic factor D values in children with steroid responsive idiopathic nephrotic syndrome. J Peds 100:192-196, 1982.
Sakamoto, K.; Seeley, J.K.; Lindsten, T.; Sexton, J.; Yetz J.; Ballow, M. and Purtilo, D.T.: Abnormal anti-Epstein-Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. J Immunol 128(2):904-907, 1982.
Lindsten, T.; Seeley, J.K.; Ballow, M.; Sakamoto, K; St. Onge, S.; Yetz, J.; Alman, P. and Purtilo, D.T.: Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T-cell defects. J Immunol 129:2536-2540, 1982.
Ballow, M.; Seeley, J.; Rickles, F.R.; Sakamoto, K.; St. Onge, S. and Purtilo, D.T.: Familial chronic mononucleosis. Ann Intern Med 97:821-825, 1982.
Ballow, M.; Mendelson, L.; Donshik, P.C.; Rapacz, P.; Sparks, K.: IgG Specific antibodies to rye grass and ragweed pollen antigens in patients with vernal conjunctivitis. Am J Ophth 95:161-168, 1983.
McLean, R.H.; Kennedy, T.L.; Ballow, M. and Siegel, N.: Increased frequency of factor B fast variant (BF*F) in the nephrotic syndrome. D isease Markers 1:25-32, 1983.
Sparks, K. and Ballow, M.: The indirect ELISA for quantification of specific antibody: Analysis of antibody dilution curves. Diagnostic Immunology 1:269-275, 1983.
Sedgwick, A.K.; Ballow, M.; Sparks, K. and Tilton, R.C.: A rapid quantitative micro enzyme-linked immunosorbent assay (ELISA) for tetanus antibodies. J Clin Microbiol 18(1):104-109, 1983.
Donshik, P.C. and Ballow, M.: Tear immunoglobulins in contact lens-induced giant papillary conjunctivitis. Am J Ophthal 96:460-466, 1983.
Ballow, M.; Mendelson, L.; Donshik, P.; Rooklin, A. and Rapacz, P.: Pollen-specific IgG antibodies in the tear secretions of patients with allergic-like conjunctivitis. J Allergy Clin Immunol 73:376-380, 1984.
Shaskan, E.G.; Ballow, M.; Oreland, L.; Wadell, G.: Is there functional significance for dopamine antagonist binding sites on lymphoid cells? Adv Biol Psychiat 12:123-141, 1983.
Shaskan, E.G.; Ballow, M.; Lederman, M.; Margoles, S.L. and Melchreit, R.: Spiroperidol binding sites on mouse lymphoid cells: Effects of ascorbic acid and psychotropic drugs. J. Neuroimmunology. 6:59-66, 1984.
Donshik, P.C.; Ballow, M.; Luistro, A.; Samartino, L.: Treatment of contact lens induced giant papillary conjunctivitis. The CLAO Journal 10:346-350, 1984.
Clark, R.B. and Ballow, M.: Long term T-cell lines from the tears of patients with vernal conjunctivitis. J Clin Lab Immunol 15:91-94, 1984.
White, W.B.; Shornick, J.K.; Grant-Kels, J.M.; Ballow, M.: Erythroderma with spongiotic dermatitis: association with common variable hypogammaglobulimenia. American J Med 78:523-528, 1985.
DuBois, R.E.; Seeley, J.K.; Brus, I.; Sakamoto, K.; Ballow, M.; Harada, S.; Bechtold, T.A.; Pearson, G.; Purtilo, D.T.: Chronic mononucleosis syndrome. Southern Medical Journal 77:1376-1382, 1984.
White, W.B.; Ballow, M.: Modulation of suppressor cell activity by cimetidine in patients with common variable hypogammaglobulinemia: New England J Medicine 312:198-202, 1985.
Ballow, M.; Hirschhorn, R.: Varicella pneumonia in a bone marrow transplanted, immune reconstituted adenosine deaminase deficient patient with severe combined immunodeficiency disease. J Clin Immunology 5 (3): 180-186,1985.
Ballow, M.; Donshik, P.C.; Mendelson, L.: Complement proteins and C3 anaphylatoxin in the tears of patients with conjunctivitis. J Allergy Clin Immunol 76:473-476,1985.
Gerber, M.A.; Rapacz, P.; Kalter, S.S.; Ballow, M.: Cell-mediated immunity in cat-scratch disease. J Allergy Clin Immunol 78:887-890, 1986.
Gerber, M.A.; Sedgwick, A.K.; MacAlister, T.J.; Gustafson, K.B.; Ballow, M.; Tilton, R.C.: Isolation of the etiologic agent of cat scratch disease, Lancet I:1236-1239,1985.
Ballow, M.; Cates, K.L.; Rowe, J.C.; Goetz, C.; Desbonnet, C.: Development of the immune system in the very small (less than 1500 gm) premature infant: Plasma immunoglobulin concentrations and pattern of infections. Ped Research, 20:899-904,1986.
Ballow, M.; Cates, K.L.; Rowe, J.C.; Goetz, C.; Panschenko, A.G.: Peripheral blood T-cell subpopulations in the very low birth weight (less than 1500 Gm) infant. Am J Hematology 24:85-92, 1987.
Ballow, M: The role of interleukins in Immunoregulation. Infections in Medicine. 4 (4) 167-172, 1987.
Ballow, M.; Donshik, P.C.; Rapacz, P.; Samartino, L.: Tear lactoferrin levels in patients with external inflammatory ocular disease. Investigative Ophthalmol Visual Science 28:543-545, 1987.
White, W.B.; Desbonnet, C.R., Ballow, M.: Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia. Am J Med 83:431-436, 1987.
Hyams, J.S.; Ballow, M.; Leichtner, A.M.: Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology 93:890-893, 1987.
Cates, K.L.; Goetz, C.; Rosenberg, N.; Pantschenko, A.; Rowe, J.C.; Ballow, M.: Longitudinal development of specific and functional antibody in very low birth weight premature infants. Ped Research 23(1): 14-22,1988.
Rapacz, P.; Donshik, P.C.; Tedesco, J.; Ballow, M.: Tear lysozyme levels in patients with contact lens-induced giant papillary conjunctivitis. CLAO Journal, 14(4): 207-209, 1988.
Rubin, K.R.; Ballow, M.;Baron, R.; Greenstein, R.M.; Raisz, L.G.; Rowe, D.W.: Malignant Osteoporosis and Defective Immunoregulation. J Bone Mineral Research. 3(5):509-16, 1988.
Whittum-Hudson, J.; Ballow, M.; Zurier, R.B.: Effect of PGE 1 Treatment on In Vitro Thymocyte Function of Normal and Autoimmune Mice. Immunopharmacology 16:71-78,1988.
Ballow, M.; Donshik, P.C.; Rapacz, P.; Maenza, R.; Yamase, H.: Immunological Responses in Cynomolgus Monkeys to Lense from Patients with Contact Lense-Induced Giant Papillary Conjunctivitis (GPC). The CLAO Journal, 15(1): 64-70, 1989.
Kohn, DB; Mitsuya, H; Ballow, M; Selegue, JE; Barankiewicz, J; Cohen,A; Gelfand, E; Anderson, WF; Blaese, RM.: Establishment and characterization of adenosine deaminase (ADA)-deficient human T cell lines. J Immunol. 142(11): 3971-7,1989 .
Rubinstein, E. and Ballow, M. Isolation of monocyte-depleted and monocyte rich fractions from human mononuclear cells. J Clin Lab Immunol, 30:35-39,1989.
Parke, A; Maier, D; Wilson, D; Andreoli, J; Ballow, M. Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy [letter]. Ann-Intern-Med. 110(6): 495-6,1989.
Ballow, M; White,W; Desbonnet ,C. Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulin. J. Allergy Clin Immunol. 84 (4, part 2): 595- 602, 1989.
Ballow, M and Parke, A. The use of intravenous immune globulin in collagen vascular disorders. J Allergy Clin Immunol. 84(4, pt 2): 608-612, 1989.
Cano, F; Mayo D.R., Ballow, M.: Absent Specific Viral Antibodies in Patients with Transient Hypogammaglobulinemia of Infancy. J Allergy Clin Immunol 85(2):510-513, 1990.
Lantner, R.; Ballow M.: Idiopathic anaphylaxis. J Allergy Clin Immunol, (Letter) , 85 (2): 529, 1990.
Israel H, Odziemiec C, Ballow M. The Effects of Retinoic Acid on Immunoglobulin Synthesis by Human Cord Blood Mononuclear Cells. Clin Immunol Immunopath 59: 417-425,1991.
Ballow M. Mechanisms of action of intravenous immune serum globulin therapy and potential use in autoimmune connective tissue diseases. Cancer 68(6): 1430-1436, 1991.
Gandhi A, Brodsky L, Ballow M. Benefits of antibiotic prophylaxis in children with chronic sinusitis: assessment of outcome predictors. Allergy Proc 14:37-43, 1993.
Wang W, Napoli JL, Ballow M: The effects of retinol on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells. Clin and Exp Immunol 92:164-168, 1993.
Wang W and Ballow M: The effects of retinoic acid on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells. Cellular Immunology, 148:291-300,1993.
Thornton CA and Ballow M. Safety of intravenous immunoglobulin (Editorial). Arch Neurology, 50:135-136, 1993.
Bernstein J, Rich G, Odzimiec C, and Ballow M. Are thymus derived lymphocytes (T-cells) defective in the nasopharyngeal and palatine tonsils of children. Otolaryngology Head Neck Surg 109:693-700, 1993.
Hirschhorn R, Yang DR, Insel RA, and Ballow M. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase messense mutation (Arg253Pro) Cell Immunol 152(2):383-393, 1993.
Braden GL, Warzynski MJ, Goligntly M, Ballow M. Cell mediated immunity in allopurinol-induced hypersensitivity. Clin Immunol Immunopath, 70:145-151, 1994.
Ballow M. Mechanisms of action of intravenous immune serum globulin therapy. Pediatr Infect Dis J 13(9):806-811, 1994.
Greenberg SJ, Choi Y, Ballow M, Du T, Ward P, Richert MH, Frankel S, Bernstein S, and Brecher M. Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia. J Leukoc Biol, 57(6): 856-864, 1995.
Choi Y, Rickert MH, Ballow M, and Greenberg SJ. Human IgH-V Gene repertoire in neonatal cord blood, adult peripheral blood, and EBV-transformed cells. Ann NY Acad Science, 764:261-264, 1995.
Schaffer FM, Ballow M. Immunodeficiency: The office work-up. J Resp Dis 16:523-541, 1995.
Weiping W, Ballow M. Retinoic-acid-induced enhancing effects of immunoglobulin synthesis by human B cells. Int Arch Allergy Immunol 107(1-3):370-371, 1995.
Choi Y, Greenberg SJ, Du TL, Ward PM, Overturf PM, Brecher ML and Ballow M. Clonal evolution in B-lineage acute lymphoblastic leukemia by contemporaneous V H-V H gene replacements and V H-DJ H gene rearrangements. Blood 87: 2506-2512, 1996.
Ballow M, Xiang S, Wang W, Brodsky L. The effects of retinoic acid on immunoglobulin synthesis: Role of interleukin 6. J Clin Immunol, 16:171-179, 1996.
Ballow M, Wang W, Xiang S. Modulation of B-cell immunoglobulin synthesis by retinoic acid. Clin Immunol Immunopath, 80: S73-81, 1996.
Ballow M, Xiang S, Greenberg SJ, Brodsky L, Allen C, Rich G. Retinoic acid-induced modulation of IL-2 mRNA production and IL-2 receptor expression on T-cells. Int Arch Allergy (Special issue: "Allergy: A disease of Modern Society") 113, No.1-3, 1997.
Ramesh S, Brodsky L, Afshani E, Pizzuto M, Ishman M, Helm J, Ballow M. Therapeutic trial (open) of intravenous immune serum globulin in chronic sinusitis in children. Annals of Allergy, 79:119-24, 1997
Ballow M. Mechanisms of Action of IVIG in Autoimmune and Inflammatory Diseases. J Allergy Clin Immunol, 1997;100:151-7
Markert M. Louise, Kostyu Donna D., Ward Frances E., McLaughlin Tanya M., Watson T.J., Buckley Rebecca H., Schiff Sherrie E., Ungerleider Ross M., Gaynor J. William., Oldham Keith T., Mahaffey Samuel M., Ballow Mark, Driscoll Deborah A., Hale Laura P., Haynes Barton F.. Successful Formation of a Chimeric Human Thymus Allograft Following Transplantation of Cultured Postnatal Human Thymus. The Journal of Immunology, 1997 158:998-1005
Bernstein JM, Ballow M, Xiang S, O'Neil K: Th1/Th2 Cytokine profiles in the nasopharyngeal lymphoid tissues of children with recurrent otitis media. Annals Otology Rhinol Laryngol, 107(1): 22-7, 1998.
Ballow, M. Editorial, Is steroid-dependent asthma a disease treatable with intravenous immunoglobulin? Clinical Immunology, 91(2): 123-25, 1999.
Ballow, M. Letter to the Editor, Reply. Clinical Immunology, 93(2): 186, 1999.
Aronica M, Duffy L, Ballow M: Survey of quality of care for asthmatic children seen in a pediatric emergency room. Pediatric Asthma, Allergy and Immunology, 13(2): 67-77, 1999.
Arkachaisri T, Ballow M: Intravenous immune globulin in autoimmune and allergic diseases: mechanisms of action. Canadian Journal of Allergy and Clinical Immunology, 5(2):60-68, 1999.
Thaschawee Arkachaisri and M Ballow. Developmental Immunology of the Newborn. Immunology & Allergy Clinics of North America, 19(2);253-279, 1999.
Woroniecka M and Ballow M, "Office evaluation of children with recurrent infection", Pediatric Clinics of North America, 47(6);1211-1224, 2000.
Ballow M, Canonica GW. An introduction to Current Opinion in Allergy and Clinical Immunology. Current Opinion in Allergy and Clinical Immunology 1:1, 2001.
Bernstein JM, Ballow M, Rich G: Detection of intracytoplasmic cytokines by flow cytometry in adenoids and peripheral blood lymphocytes of children. Annals of Otology, Rhinology & Laryngology. 110(5): 442-446, 2001.
Thampakkul S and Ballow M. "Replacement intravenous immune serum globulin therapy in patients with antibody immune deficiency", Allergy and Immunology Clinics of North America, 21:165-184, 2001.
Ballow M: Primary immunodeficiency disorders: antibody deficiency. Journal of Allergy and Clinical Immunology, 109, 581-591, 2002.
Ballow M. Intravenous immunoglobulins: clinical experience and viral safety. [Review] [81 refs] Journal of the American Pharmaceutical Association. 42(3):449-58; quiz 458-9, 2002
Singh, H, and Ballow M. "Role of Cytokines in Nasal Polyposis". Journal of Investigational Allergology and Clinical Immunology,13(1): 6-11, 2003.
Ballow M, Wang X, Xiang S, Allen C. "Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells". Journal of Clinical Immunology 23(1):46-54, 2003.
Roifman CM, Schroeder H, Berger M, Sorensen R, Ballow M, Buckley RH, Gewurz A, Korenblat P, Sussman G, Lemm G. "Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial." International Immunopharmacology. 3(9):1325-33, 2003
Ballow M. Berger M. Bonilla FA. Buckley RH. Cunningham-Rundles CH. Fireman P. Kaliner M. Ochs HD. Skoda-Smith S. Sweetser MT. Taki H. Lathia C. "Pharmacokinetics and Tolerability of a New Intravenous Immunoglobulin Preparation, IGIV-C, 10% (Gamunex ™, 10%)" Vox Sanguinis, 84(3):202-210, 2003
Bernstein JM, Ballow M, Schlievert PM, Rich G, Allen C, Dryja D. "A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis." American Journal of Rhinology 17(6):321-326, 2003.
Kim JB and Ballow M. "Progressive muscle weakness in a 4-year-old female" Annals of Allergy, Asthma and Immunology, 92(1):19-24, 2004.
Bernstein JM. Ballow M. Rich G. Allen C. Swanson M. Dmochowski J. "Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp?" Otolaryngology - Head & Neck Surgery. 130(5):526-35, 2004
Reed VA, Jernstedt GC, Ballow M, Bush RK, Gewurz AT, McGeady SJ. "Developing Resources to Teach and Assess the Core Competencies: A Collaborative Approach". Academic Medicine, 79:1062-1066, 2004.
Wang X, Ballow M. "Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-α from LPS-stimulated monocytes/macrophages". Submitted 2005.

Books, Chapters, Monographs

Gatti, R.A.; Ballow, M. and Good, R.A.: Bone marrow transplantation for acute lymphocytic leukemia. In: Tissue Typing and Organ Transplantation. Eds.: E.J. Yunis; R.A. Gatti; D.B. Amos. Academic Press: New York, 1973, pp. 437-449.
Ballow, M.; Dupont, B.; Hansen, J. and Good, R.A.: Transfer factor therapy: Evidence for non-specificity. I n: Immunodeficiencies in Man and Animals, Birth Defect Series, Original Article Series. Eds.: R.A. Good; J. Finstad and D. Bergsma. Sinauer Association, Inc.: Massachusetts. XI:1, 1975. pp 457-361.
Ballow, M.: Phylogeny and ontogeny of the complement systems. In: Biological Amplifications Systems in Immunity. Eds.: N.K. Day and R.A. Good, Plenum Publishing Co.: New York, Vol. 5, pp. 183-204, 1977.
McLean, R.H.; Ballow, M. and Ward, P: Complement in Health and Disease. In: Differential Diagnosis and Treatment of Pediatric Allergy. Eds.: B.A. Berman, K.F. MacDonnell. Little, Brown & Co., Boston, 1981.
Cates, L. and Ballow, M.: Host defenses in the newborn. In: Merck Manual, 1982, pp 287-288.
Cates, L.; Rowe, J.; Ballow, M. The premature infant as a compromised host. I n: Current Problems in Pediatrics, Year Book Medical Publishers. June, 1983.
Ballow, M. New developments in allergic rhinitis and conjunctivitis. Postgraduate Medicine, 76 (1) 197-205, 1984.
Ballow, M. : In vivo analysis of cell-mediated immunity. In: Investigation of Cell-Mediated Immunity. Ed.: T. Yoshida. Practical Methods in Clinical Immunology, Churchill Livingstone, Edinburgh, 1985.
Ballow, M. and Quintiliani, R.; Maderazo, E.: Clinical Crisis in Immune Deficiency: Mechanisms of Acquired Immunocompromise. SCP Communications, N.Y., 1984.
Ballow, M. and Quintiliani, R.: Opportunistic invaders in immune deficient states: A Study of Pseudomonas and Herpes Viruses. SCP Communications, N.Y., 1985.
Donshik, P.C. and Ballow, M.: The Immunologic Components of Tears In: Biomedical Fd of Ophthal, Chptr 37, ED: T. P.Duane, pg 1-5, Harper & Row Publishers, Philadelphia, 1986.
Ballow, M.; Nezelof Syndrome In : Birth Defect Encyclopedia, ed. ML Buyse, Blackwell Scientific Publications, Cambridge, MA, 1990, pp 956-7.
Ballow, M. and Markowitz, M.: Immunology, Allergic Disease and Rheumatic Disease In: Pediatrics ed P. Dworkin, Harval Publishing Company 1987. Chapter 7, pg 165-184.
Donshik, P.C.; Luistro, A.; Ballow, M.: Giant Papillary Conjunctivitis in Contact Lenses ed F. Weinstock, Gower Medical Publishing Limited 1987. pp10.1-10.18.
Ballow, M; and White, W.B.: Modulation of Immune Responses by Histamine-2 antagonists in Primary Immune Deficiency Diseases. in Histamine and H 2 Antagonists in Inflammation and Immunodeficiency, ed. R. Rocklin. Marcel Dekker, Inc. pp 219-229, 1989.
Lantner, R; Ballow, M.: Diseases of Allergy: Anaphylaxis and Serum Sickness In Conn's Current Therapy, R. Rakel, W.B. Saunders Co., pp 673-676, 1990.
Ballow,M. Office Evaluation of Patients with Recurrent Infections. Current Views in Allergy and Immunology, July, Vol XIX, 1990.
Ballow M (editor): "Future directions of immunoglobulin therapy", J Clinical Immunol. 10(6): Nov. Suppl, 1990.
Ballow, M. and Markowitz, M.: Immunology, Allergic Disease and Rheumatic Disease In: Pediatrics ed P. Dworkin, Harval Publishing Company. Chapter 7, edition 2, 1990.
O'Neil K and Ballow M., "Approach to the patient with recurrent infections". In: Allergy: Principles and Practice, eds Middleton, Ellis, Reed, et al. Fourth Edition, St. Louis MO, pp1027-1058, Mosby-Year Book, 1992.
Ballow M (editor): "IVIG Therapy Today" In: Clinical Reviews in Allergy, 10(1-2), 1-146, 1992.
Ballow M (editor): "Future directions of cytokine and immunoglobulin therapy", Clinical Immunology and Immunopathology, 62(1): part 2, 1992.
Ballow M and others. MKSAP - AI, American College of Physicians, Philadelphia, PA., 1993.
Ballow M (editor). "IVIG Therapy Today" Humana Press, Totowa, New Jersey, 1992.
Ballow M (Guest Editor). "Recent Advances in the Pathophysiology of Primary Immune Deficiencies and Immunoglobulin Therapy in HIV Infection and Autoimmune/Inflammatory Neurological Disorders" Pediatric Research 33(1)[Suppl]: 1993.
Ballow M, and Schaffer F. "Molecular genetics of immunoglobulin genes and the generation of antibody diversity." In: Molecular and Cellular Biology of the Allergic Response. ed. A Levinson and Y Paterson. Marcel Dekker, Inc, 1994.
Ballow, M. , Markowitz, M., and Robinson J: Immunology, Allergic and Rheumatic Diseases In: Pediatrics; ed: P. Dworkin, Williams & Wilkins, Chapter 9, 3rd edition, 1995.
Boguniewicz M, Kelly CS, Ballow M, and Leung DYM. "Intravenous immune globulin in autoimmune and inflammatory diseases" in Clinical Immunology. (eds) RR Rich; CV Mosby Year Book, St. Louis, MO, pp 1891-1903, 1996.
M Ballow and R Nelson. "Immunopharmacology: Immunomodulation and Immunotherapy", in Primer on Allergic and Immunologic Diseases, JAMA 278 (22): 2008-2017, 1997.
Ballow, M (Section Editor): for "Allergy, Immunology, and Pediatric Rheumatology" in Saunders Manual of Pediatric Practice, (eds) Laurence Finberg, pp 224-293, 1998.
Ballow M and O'Neil K. "Approach to the Patient with Recurrent Infections" " in Allergy: Principles and Practice, eds Middleton, Ellis, Reed, et al. Fifth Edition, St. Louis MO, Chapter 53, CV Mosby-Year Book, pp 735-759, 1998.
Bernstein JM, Rich G, Ballow M. Inhibition of human neutrophil migration in vitro by common pathogens of the upper respiratory tract: implications in otitis media . In: Lim, Bluestone, Klien, Ogra, Bakaletz & DeMaria (Eds.) Proceeding's of the Seventh International Symposium on Recent Advances in Otitis Media with Effusion, B. C. Decker, Inc., Toronto, Ontario, Canada, pp. 534-538, 1999.
Ballow M and Strober W (Topic Editors) for "Primary Immune Deficiencies", Clinical Reviews in Allergy and Immunology, 19: 79-215, 2000.
Ballow M and Strober W (Topic Editors) for "Cellular Immune Deficiencies", Clinical Reviews in Allergy and Immunology, 20: 1-158, 2001.
Boguniewicz M, and Ballow M, "Intravenous immunoglobulin in autoimmune and inflammatory diseases" in Clinical Immunology. (eds) RR Rich; CV Mosby Year Book, St. Louis, MO, 2001, pp. 104.1-104.12.
Ballow M. "Intravenous immune serum globulin (IVIG) therapy in patients with antibody immune deficiency" in Pediatric Allergy: Principles & Practice (eds: DYM Leung, HA Sampson, RS Geha, SJ Szefler) Mosby, St. Louis, 2003. pp183-192.
R Nelson and Ballow,M. " Immunomodulation and Immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies" , J Allergy Clin Immunol 2003; 111:S720-32.
Ballow M and O'Neil K. "Approach to the Patient with Recurrent Infections" in Allergy: Principles and Practice, eds Adkinson Jr., Yunginger, Busse, et al. Sixth Edition, Volume 2, St. Louis MO, Chapter 60, pp 1043-1072, 2004.
Ballow M. "Secondary Immunodeficiencies "Stress-Related Immunodeficiencies: Trauma, Surgery, Anesthesia, Burns, Exercise, and Splenic Deficiencies" " in Immunologic Disorders in Infants and Children (eds) R. Stiehm, Ochs HD, Winkelstein JA. 5 th Edition, Chapter 30, pp 952-964, 2004.

Abstracts and Workshop Reports

Edelson, P. and Ballow, M.: Speculation of cause of deficiency of Hageman factor. J. Pediatr. (Letter to the Editor) 80:158, 1972.
Gatti, R.A.; Robinson, W.A.; Deinard, A.S.; Nesbit, M.; Ballow, M. and Good, R.A.: Studies on the pathogenesis and treatment of chronic myelogenous leukemia. European Society for Pediatric Hematology and Immunology, Hamburg, September 9-10, 1972 (abstract).
Ballow, M.; Day, N.K.B.; Good, R.A.: Depletion of early complement components during systemic graft-versus-host-reaction in rats. Fifth Complement Workshop. J. Immunol. 111:303, 1973 (abstract).
Ballow, M.; Day, N.K.B.; Biggar, W.D.; Park, B.H. and Good, R.A.: Reconstitution of serum Clq following bone marrow transplantation in patients with severe combined immunodeficiency disease. Fifth Complement Workshop. J. Immunol. 111:303, 1973 (abstract).
Ballow, M.; Yang, S.Y. and Day, N.K.: Complete absence of the third component of complement. Fed. Proc. 34:853, 1975 (abstract).
Ballow, M.; Ward, G.W., Jr.; Wilbur, R. and Day, N.K.: Abnormal serum complement profile in patients with idiopathic chronic urticaria. Am. Acad. Allergy, 31st meeting, 1975 (abstract).
Ballow, M. and Good, R.A.: Transfer factor therapy in a patient with an isolated T-cell deficiency. In Transfer Factor: Basic Properties and Clinical Applications. Eds.: M. Ascher; R. Gottlieb and C. Kirkpatrick. Academic Press: New York, 1976, pp. 623-632.
Ballow, M. and Hyman, L.: Immunological reconstitution of chronic mucocutaneous candidiasis with transfer factor and fetal thymic tissue. In: Transfer Factor: Basic Properties and Clinical Applications. Eds: M. Ascher; R. Gottlieb and C. Kirkpatrick. Academic Press: New York, 1976, pp 503-508.
Ballow, M.; Incefy, G.S.; Good, R.A. and Pahwa, R.: Severe combined immunodeficiency with B lymphocytes, antibody synthesis and response to allogeneic cells in MLC. Pediatric Research 11(4):484, 1977.
Einstein, L.P.; Hauser, P.J.; Alper, C.A.; Davis, J.S.; Rosen, F.S.; Ballow, M. and Colten, H.R.: Monocyte from patient with genetic deficiency of the third component of complement (C3) produce C3 in vitro. Ped. Res. 11(4):486, 1977.
Rickles, F.R. and Ballow, M.: Defective mononuclear cell tissue factor (MCTF) generation in severe combined immunodeficiency disease. Clin. Res. 26(3):520A, April, 1978.
Ballow, M.; McLean, R.; Damjanov, I. and Lowenstein, M.: Autoimmunity, changes in B cell function and transfer factor therapy. Third International Workshop on Transfer Factor, fall, 1978.
Ballow, M.: Enhancement of IgM synthesis in vitro by dialyzable transfer factor. Third International Workshop on Transfer Factor, fall, 1978.
Lovett, E.J.; Lundy, J. and Ballow, M.: N-acetylacetyl thioacetamide (084): A new nonspecific immunopotentiator. Annual meeting of American Association of Cancer Research, April, 1978.
Zimmerman, A.W.; Sanders, W.M. and Ballow, M.: Histamine release in migraine. Neurology 29:550, 1979.
Ballow, M. and Mendelson, L.: Specific IgE antibodies in the tear secretions of patients with vernal conjunctivitis. American Academy of Allergy, spring meetings, 1979.
O'Neill, G.J.; Berger, R.; Miniter, P.; Yunis, E.J.; Dupont, B. and Ballow, M.: The Rodgers antigenic determinant is present on functionally active C4 only. VIII International Histocompatibility Testing Workshop, Los Angeles, CA. February, 1980.
O'Neill, G.J.; Berger, R.; Miniter, P.; Yunis, E.J.; Dupont, B. and Ballow, M.: Rodgers antigen on functionally active C4. IV International Congress of Immunology, 1980.
McLean, R.H.; Kennedy, T.L., III; Ballow, M. and Siegel, N.J.: Increased frequency of the BfF gene in the idiopathic nephrotic syndrome (INS): Studies of the alternative complement pathway in INS. Pediatric Research. 14:1012, 1980.
Ballow, M. and Pantschenko, A. Effect of ADA inhibitors on murine lymphocyte subpopulations. Fed Proc 40:1081, 1981.
Ballow, M.; Brakoniecki, J.; Mendelson, L.; Sparks, K. and Chu, E.: Immune responses following natural sting by honey bee and yellow jacket insects. Pediatric Research 15:592, 1981.
Ballow, M.; Siegel, N.J.; Kennedy, T.L.; and McLean, R.H.: Serum Factor D hemolytic activity in children with idiopathic-nephrotic syndrome. J Allergy Clin Immunol 67(Suppl):54, 1981.
Krause, P.J.; Hyams, J.S.; Ballow, M. and Klemos, B.W.: Nosocomical rotavirus infection in neonatal intensive care unit. Interscience Conf. Antimicrob. Agents Chemotherapy. 21:704A, 1981.
Ballow, M.; Mendelson, L.; Donshik, P.C. and Sparks, K.: IgG specific antibodies to Rye Grass and Ragweed antigen in patients with Vernal Conjunctivitis. J Allergy Clin Immunol 695:46, 1982.
Seeley, J.; Lindsten, T.; Ballow, M.; Sakamoto, K. and Purtilo, D.: Defective lymphocyte function in X-linked lymphoproliferative syndrome in Comparative Research on Leukemia and Related Diseases. Ed. D. Yoka. Elservier, North Holland, 1981.
Shaskan, E.G.; Ballow, M. and Margoles, S.: Dopamine Antagonist Binding Sites on Murine Lymphoid Cells. In: Res Commun. Psychol Psychiat and Behav 5:241-254, 1980 (abstract).
Donshik, P.C. and Ballow, M.: Tear Immunoglobulins in Giant Papillary Conjunctivitis Assoc. for Research in Vision and Ophth. 1982 (abstract).
Donshik, P.C.; Ballow, M.; Mendelson, L.: IgG Specific Antibodies in the Tear Secretions of Patients with Vernal Conjunctivitis. Ocular Microbiology and Immunology Group. San Francisco, October 30, 1982.
Ballow, M.; Mendelson, L.; Rooklin, A.; Donshik, P.C.: Pollen-Specific IgG Antibodies in Tears. J Allergy Clin Immunol 71(Pt 2):123, 1983.
Rubin, K.; Cassidy, S.; Ballow, M.; Greenstein, R.; Raisz, L.; Rowe, D.: Enhanced bone resorption and abnormalities in immunoregulation. Pediatric Research 17(4):171A, 1983 (abstract).
Ballow, M.; Donshik, P.; Mendelson L.: Complement proteins and C3 anaphylatoxin in the tears of patients with conjunctivitis. J Allergy Clin Immunol, 73, pt 2:150, 1984.
Ballow, M.; Cates, K.L.; Rowe, J.C.; Goetz, C.: Developmental aspects of the immune system in very small premature infants. Society for Pediatric Research, 1984.
White, W.B.; Ballow, M.; Desbonnet, C.R.: Cimetidine modulates suppressor activity in common variable hypogammaglobulinemia. Clin Research 32:362A, 1984.
Ballow, M.; Donshik, P.C.: Complement proteins and C3 anaphylatoxins in the tears of patients with conjunctivitis. I nvest Ophthal Visual Sci 25 (suppl):26, 1984.
Tannenbaum, A.S.; Ballow, M.; Gelfand, E.; Gupta, S.; Hong, R.; Olseke, J.; Pahwa, S.; Pirofsky, B.; Schwarts, S.; Steele, Wara, D.; Caruso, F.S.: Clinical experience with a native intravenous immune globulin, J Allergy Clin Immunol, 1984.
Gerber, M.A.; Sedgwick, A.K.; Ballow, M.; Tilton, R.C.: Isolation of the etiologic agent of cat scratch disease (CSD). Society for Ped Research, Spring, 1985.
White WB, Ballow M, Desbonnet C. Intravenous gammaglobulin induces and/or enhances suppressor cell activity in common variable hypogammaglobulinemia. Clin Research 34:510A, 1986.
White WB, Ryan RW, Staley D,Ballow M. Transfer of antibody to human T-lymphotropic virus type III (anti-HTLV III) in patients receiving high dose intravenous gammaglobulin. Clin Research 34: 510A, 1986.
Cates LK, Ballow M, Rowe JC, Goetz C. Specific and functional antibody responses in very low birth weight (VLBW) infants. Ped Research 20: 388A, 1986.
Ballow M, Donshik PC, Rapacz P. Tear lactoferrin levels in patients with vernal conjunctivitis and contact lens-induced GPC. J Allergy Clin Immunol 77:174, 1986.
Kohn DB, Selegue JE, Ballow M, and Blaese RM. Establishment and characterization of adenosine deaminase ( ADA)-deficient T-cell lines. Ped Research 1987.
Hyams JS, Ballow M, Leichtner AM. Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterological Research 1987.
Donshik PC, Tedesco J, Rapacz P, and Ballow M. Tear lysozyme levels in patients with contact lens-induced giant papillary conjunctivitis. ARVO , 1987
Ballow M, Rapacz P, Maenza R, Yamase H, and Donshik PC. An animal model for contact lens-induced giant papillary conjunctivitis (GPC). ARVO,1987.
Rosenkrantz TS, Phillips F, Krause P, Ballow M, Thrall R, Forouhar F, Raye JR: Immunologic effects of early steroid administration in very low birth weight (VLBW) infants. Society for Pediatric Research, 1988.
Cano F. and Ballow M.: Delayed maturation hypogammaglobulimenia: clinical and laboratory features. American College of Allergy and Immunology 1988.
Ballow M. Intravenous Immune serum globulin therapy in autoimmune connective tissue diseases. (15th International Cancer Congress, Aug 16, 1990) J Cancer Res Clin Onc 116 (pt II)S:781, 1990.
Israel H, Odziemiec C and Ballow M. Effects of retinoic acid on immunoglobulin production by human neonatal mononuclear cells. J Allergy Clin Immunol 85(1): pt 2:219, 1990.
Gandhi A; Israel H; Rockoff J; Brodsky L; and Ballow M. Recurrent sinusitis and antibody deficiency. J Allergy Clin Immunol 85(1): pt 2:235, 1990.
Ressler C, Greaney MD, Tatake JG, Brettman LR and Ballow M. Immunologic Cross-Reactivity in vitro between sulfamethoxazole and various other sulfur and related drugs. J Allergy Clin Immunol 85 (1, pt2):156, 1990.
Donovan KM, Cano F, Ballow M. Hematemesis secondary to theophylline toxicity by oral administration. Annals of Allergy, 1991.
Gandhi A, Ballow M. Chronic sinusitis and Antibiotic Prophylaxis. Presented at the 47th Annual Meeting of the American Academy of Allergy and Immunology, San Francisco, California, March 1-5, 1991. J Allergy Clin Immunol 87(1):219, 1991.
Cano F, Donovan KM, Ballow M. Hematemesis secondary to theophylline toxicity by oral administration. Presented at the 47th Annual Meeting of the American Academy of Allergy and Immunology, San Francisco, California, March 1-5, 1991. J Allergy Clin Immunol 87(1):277, 1991.
Israel H, Odziemiec C, Ballow M. The Effects of Retinoic Acid on Immunoglobulin Synthesis by Human Cord Blood Mononuclear Cells. Pediatric Research 29 (4, part 2): 155A, 1991.
Cano F, Ballow M. Effects of Danazol on immunoglobulin production by adult peripheral blood mononuclear cellls. J Allergy Clin Immunol , 89(1)pt2: 265, 1992.
Helm J, Cano F, O'Neil K, Ballow M. PEG-ADA treatment of a patient with adenosine deaminase deficiency. J Allergy Clin Immunol , 89(1) pt2: 264, 1992.
Anne A, Agarwal R, DiBisceglie A, Ballow M. False positive hepatitis-C serology in patients receiving intravenous immune globulin (IVIG). (Abstract) Presented American College of Allergy and Immunology, Chicago, Illinois, November 14-15, 1992. Annals of Allergy 70:52, 1993
Bernstein J, Borgeson L, and Ballow M. Are thymus derived lymphocytes (T-cells) dysfunctional in the nasopharyngeal tonsils of children with otitis media with effusion (OME)?. Submitted, American Academy of Otolaryngology, 1992.
Ballow M, and Weiping W. Retinoic acid (RA)-induced enhancing effects on immunoglobulin (Ig) synthesis of human B-cells. Accepted for presentation at Collegium Internationale Allergologicum, Nantucket, MA September 25-29, 1994.
Ramesh S, Ballow M. Manifestations of Clinical Symptoms in a Carrier of CGD. Presented at the American Academy of Allergy and Immunology, Anaheim, California, March 13, 1994. J Allergy Clin Immunol 93:171, 1994.
Anne S, Agarwal R, Nair MP, Schwartz SA, Ballow M, Kandaswami C, Middleton, Jr. E. Inhibition of endotoxin-induced expression of intercellular adhesion molecule-1 and of leukocyte adhesion to endothelial cells by the plant flavonol Querctin. Presented at the American Academy of Allergy and Immunology, Anaheim, California, March 13, 1994. J Allergy Clin Immunol 93: 276, 1994
Choi Y, Du T-L, Ward P, Overturf P, Brecher M, Ballow M, Greenberg SJ. Molecular mechanisms of clonal evolution in B-linage acute lymphoblastic leukemia. Submitted to Clinical Research Meeting, April 29-May 2, 1994. Clinical Research 42:125A, 1994.
Melgar L, Ramesh S, O'Neil K and Ballow M. Maintenance of desensitization in a ticarcillin allergic patient with cystic fibrosis (CF), Presented at American College of Allergy and Immunology, November 6, 1994. Annals of Allergy
Ramesh S, Helm J, Brodsky L, Afshani E, Pizzuto, Ishman M and Ballow M. Preliminary trial of IVIG in children with recurrent sinusitis. Presented at the American Academy of Allergy and Immunology, February 1995. J Allergy Clin Immunol 95:200, 1995
Bommanna VM, Polasani R, Ballow M. Adverse reaction to porcine heparin. Presented at the American Academy of Allergy, Asthma and Immunology, March 20, 1996, New Orleans, LA. J Allergy Clin Immunol 97:341, 1996.
Hickey RW, Ballow M. Exercise-induced anaphylaxis associated with apple juice ingestion. Presented at the American Academy of Allergy, Asthma and Immunology, March 20, 1996, New Orleans, LA. J Allergy Clin Immunol 97:351, 1996.
Bommanna V, Ballow M, KM O'Neil. Protein Losing Enteropathy Presenting as Recurrent Sinusitis, Hypogammaglobulinemia, and Severe Lymphopenia. Presented at the AAAAI/AAI/CIS Joint Meeting, February 21-26, 1997, San Francisco, CA. J Allergy Clin Immunol 99:S393, 1997.
Velazquez V, Arkachaisri T, Alt L, Ballow M. Milk and Soy Sensitivity Presenting with Anemia and Pulmonary Hemorrhage. . Presented at the American Academy of Allergy, Asthma and Immunology, March 13-18, 1998. J Allergy Clin Immunol 101:S89, 1998.
Velazquez V, Gaur V, Ballow M. Cryofibrinogenemia in a Pediatric Patient with Cold Urticaria. . Presented at the American Academy of Allergy, Asthma and Immunology, February 26-March 3, 1999. J Allergy Clin Immunol 103:S154, 1999.
Rich G, Ballow M, Bernstein JM. Inhibition of Human Neutrophil Migration In-vitro by NTHI, M. catarrhalis, and S. pneumoniae. Submitted to 7 th International Symposium on Otitis Media, June 1 - 5, 1999, Fort Lauderdale, Fl., 1999.
Ballow M, Berger, M, Bonilla FA, Buckley RH, Cunningham-Rundles C, Fireman, P, Kaliner M, Ochs H, Skoda-Smith, S, Sweetser M, Taki H, Lathia C. Pharmacokinetics of a Novel, Intravenous Immunoglobulin Preparation. Presented at the American Academy of Allergy, Asthma and Immunology, March 16 - 21, 2001, New Orleans, LA. J Allergy Clin Immunol 107(2).
Woroniecka A, Allen C, Ballow M. Immuno-Modulatory Effects of Retinoic Acid on IL-2 and IL-10 Gene Expression by Cord Blood Monocuclear Cells. (Abstract) Presented American College of Allergy and Immunology, Seattle, Washington, November 5 - 12, 2000. Annals of Allergy, Asthma and Immunology 86:76, 2001.
Sands M, Ramesh S, Ballow M. "Rapid Intravenous (IV) Desensitization for Desferrioxamine (DFO) Hypersensitivity Followed by IV Maintenance Therapy in an Adolescent with Sickle Cell Disease" Abstracted accepted to American College of Allergy, Asthma and Immunology (ACAAI) Conference, 2001. Annals of Allergy, Asthma & Immunology 88: 98, 2002.
Sands M, Ballow M. "Common Variable Immunodeficiency (CVID) Presenting as Nodular Granulomatous Lung Disease" Abstracted submitted to American Academy of Allergy, Asthma and Immunology (AAAAI) Conference, 2002. Journal of Allergy and Clinical Immunology, 109:S189, 2002.
Wang X, Haseeb AQ, Ballow M. Retinoic Acid Modulates Monocyte/Macrophage-Derived Cytokines from THP-1 and Cord Blood Mononuclear Cells. Abstract presentation at Federation of Clinical Immunology Societies (FOCIS) 2 nd Annual Meeting, San Francisco, California, 2002. Clinical Immunology 103:S34, 2002.
Ballow M, Wang X, Xiang S, Allen C. Expression and Regulation of Retinoic Acid Nuclear Receptors in Human Lymphoid Cells. Abstract presentation at Federation of Clinical Immunology Societies (FOCIS) 2 nd Annual Meeting, San Francisco, California, 2002.
Kim JB, Ballow M. "Juvenile Myasthenia Gravis and IVIG". Annals of Allergy, Asthma & Immunology 90:164, 2003.
Lehman H, Ballow M, Lillis K, Augustine M and Shaha S. "Initiation of Chronic Anti-Inflammatory Medications in Children with Asthma in the Pediatric Emergency Department. " Abstract to presented at 2004 Pediatric Academic Societies' Annual Meeting . Pediatric Research 55:128A, 2004.
Bayuk JL, Geller DK, Ballow M, Hirschhorn R. "A 3 Year Old Girl With Late Presentation of Adenosine Deaminase"Annals of Allergy, Asthma & Immunology 94:149, 2005.
Geller DK, Ballow, M. "The Use of IVIG in an 11 Year Old Male with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)". Annals of Allergy, Asthma & Immunology 94:155, 2005.
Carrion V, Ballow M, Duffy L, Browne R. "Vitamin A Supplementation in Preterm Infants: Vaccine Response". Pediatric Academic Societies' Annual Meeting, May 14-17, Washington, DC, 2005.
Lehman H , Ballow M, Lillis K, Augustine M, Shaha S. "Initiation of Chronic Anti-Inflammatory Medications in Asthmatic Children in a Pediatric Emergency Department." Pediatric Academic Societies' Annual Meeting, May 14-17, Washington, DC, 2005.

Active Research Grant Support

Investigator initiated-peer reviewed (Pending)-

NIH - 1 RO1A1064252-01 4/1/2005 - 3/31/2009; "Vitamin A Retinoids Effects on Airway Inflammation" -. $----------------.
PECARN 9/30/05 - 9/29/08 "Randomized Clinical Trial Comparing Two Pediatric Emergency Department Methods to Improve Compliance with National Guidelines for the Use of Chronic Inhaled Corticosteroids in Pediatric Patients with Persistent Asthma"-$------------

Clinical drug trials - active -

--------------
-------------------------------------------------------------------------------------------------------------------------------------------------------

------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------

--------------
---------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------

Past Research Grants Awarded

Hood Foundation: 7/1/75-6/30/77; Study of the effect of transfer factor on the histocompatibility system; $---------
UConn Research Foundation: 8/1/75-6/30/76; In vitro modulation of the mixed-lymphocyte culture reactivity of transfer factor; $----------.
UConn Research Foundation: 3/77-2/78; Immune mechanisms in the pathogenesis of vernal conjunctivitis; award returned.
NIH PHS Grant 1R01 AM2-975-01: 7/1/79-6/30/81; Association of the major histocompatibility system and diabetes in sacral agenesis; $82,809.
American Heart Association, CT Affiliate: 9/1/78-8/31/79; Immune function in idiopathic nephrosis; award returned.
NIH 1R23 EY02036: 8/1/77-7/31/80; Mediators of inflammation in tear secretions; $30,000.
NIH 1R01 HD 12050: 8/1/78-7/31/81; Effects of altered metabolism on immune function in nephrosis; $142,328.
UConn Research Foundation: 12/15/78-12/15/79; Adenosine deaminase deficiency - An animal model; $---------
NIH 1R01 AIl4484: 2/1/79-1/31/82; Immune responses to minor histocompatibility antigens; $138,821.
NIH 2R01-AM20975; 9/1/79-8/30/81; Immunogenetics of sacral agenesis, $82,809.
NIH, R01-EY02036 9/1/81-8/31/84; Mediators of Inflammation in Tear Secretions. $147,285.
NIH R01-H016481, 7/1/82 to 6/30/86; Human Milk and Immune Development in Premature Infants, $409,508.
UConn Research Fd 9/1/83 to 7/31/83 Contact Lens Induced Conjunctivitis $----------.
NIH EY-05189 9/1/83 to 8/31/84; Immune Mechanisms in Contact Lens Induced Conjunctivitis (co-investigator) $15,000.
Solomon Eye Fund - Immune Mechanisms in Contact Lens Induced Papillary Conjunctivitis $---------- 7/1/84 - 6/30/85.
NIH EY-02036-08, 9/30/84 to 6/30/88; Mediators of Inflammation in Tear Secretions, $259,734.
UConn Research Foundation 6/6/87 - 12/31/87; Ontogeny and B-Cell Development in VLBW Premature Infants, $--------.
Intravenous Immune Serum Globulin Therapy in Patients with SLE and Sjogren's Disease:
UConn Research Foundation - $ ---------
Cutter Laboratories - $---------
Travenol Laboratories - $--------
NIH, 7/1/88 - 5/31/93; Otogeny and B-Cell Development in VLBW Premature Infants, $543,333.
SINGULAIR Pediatric Mild Asthma Program (PMAP) Medical School Grant, "Use of a Leukotriene Modifier (Montelukast) to Improve Medication Adherence for Asthmatic Children Seen from the Inner-City"; 2000-2002 $--------.
NIH -Vitamin A Therapy in Preterm Infants: Vaccine Response. R01 HD37263. National Institute of Child Health and Human Development, National Institutes of Health; 9/15/99-8/30/00; Entire Project Period 9/15/99-8/30/04; $829,466.

Clinical studies:

---------------------------------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------
---------------------
---------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------.
--------------------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------
--------------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------

EDUCATIONAL/ADMINISTRATIVE ACTIVITIES

State University of New York at Buffalo

Peer Review Committee for BRSG Funds (1989-1991)
Facilities Planning and and Budget Committee
Incoming Residents Group Leaders Committee (1988-1991)
Residency Reallocation Working Group (1994- present)
The Theodore T. Jacobs MD Institute of Molecular Medicine and Immunology Committee (1994-95) Organizing Committee
Student Research Committee of the School of Medicine and Biomedical Sciences, 1994- present
Chair-Elect, Program Directors Committee of SUNY at Buffalo consortium, November 1995-1996
Chair, Program Directors Committee of SUNY at Buffalo consortium, 1996-1997
Medicare Demonstration Project Committee, 1998-.
Administrative Committee, Graduate Medical Education, 1997-1998
Ad Hoc Committee on Promotions to Qualified (Clinical) Ranks, 1998-2001.
Chair, 1999-2000.
Bylaws Committee for Graduate Medical Dental Education Consortium, 1999-.
Medical Scientist Training Program Admissions Committee, 1999-.

Children's Hospital of Buffalo and Department of Pediatrics Committees

Department of Pediatrics Committee on Appointments and Promotions
Space Committee (1988-1991)
Clinical Laboratory Management Committee, Chair
Radioactive Materials Safety Committee
Animal Care Evaluation Committee (1988-1992)
University Pediatric Associates Billing Committee (1990-1993)
Women's and Children's Research Foundation Advisory Committee
Pediatric Residency Recruitment Committee
Clinical Laboratory Marketing Committee
Clinical Pathology Director Search Committee (1992)
DRG/Asthma Care Committee, 1996-1997
Latex Committee to develop a latex policy for the Consortium CGF Hospitals
University of Pediatrics Information Systems Steering Committee - 1996-1997
University Pediatric Associates Finance Committee, 1996- to present
Chair of the Billing Committee
Merger committee for Clinical Laboratories for CGF Hospital* - 1997 to present
Merger committee for affiliation agreement between SUNY Buffalo and CGF, 1997- 1999.
Member, Medical Advisory Committee at Children's Hospital of Buffalo, 2001 -
Chair, Search Committee for Pediatric Pulmonary Medicine, 1998-1999
Chair, Billing Committee for the Department of Pediatrics.2000 -
Member, Board of Directors of University at Buffalo Pediatrics Associates, 2002 -

*CGF- merged hospitals of Children's, Buffalo General, and Millard Fillmore Hospitals, March, 1998

Invited Speaker (from 1990 only)

Title:"The neonate as an immunocompromised host" Grand Rounds. Department of Pediatrics,Golan Memorial Visiting Professor, North Shore University Hospital, March 7, 1990.
Title:"The neonate as an immunocompromised host" Grand Rounds, Strong Memorial Hospital, Rochester, New York April 25, 1990.
Title:"Ocular Allergy", Greater Kansas City Allergy Society, January 20, 1990
Title:"Evaluation of Patient with Recurrent Infection, Greater Kansas City Allergy Society, January 20, 1990
Title: "The Premature Infant as an Immunocompromised Host", Health Care Dimensions/Cutter Biological, Philadelphia, April 28, 1990.
Co-Chairman, The 13th National Conference on Pediatric/Adult Allergy and Clinical Immunology, Title: "Recurrent Sinusitis and Immune Deficiency", Workshop Moderator: "Allergy and the Skin", Workshop Panel: "Adverse Reactions to Antibiotics, local anesthetics and radiocontrast media", Toronto, Ontario, Canada, July 13-15,1990.
Title: "Intravenous immune serum globulin therapy in autoimmune connective tissue diseases", Recent Advances in Intravenous Immunoglobulin Therapy, 15th International Cancer Congress, Hamburg, Germany, August 17, 1990.
Title: IVIG Therapy", Symposium on Prophylaxis of Pediatric Infecious Diseases, Waterbury Hospital and St. Mary's Hospital Combined Pediatric Residency Program, Waterbury, Connecticut, October 18, 1990.
Title: "New Concepts of IVIG Therapy" , American College of Osteopathic Allergy, Las Vegas, Nevada, November 28-29, 1990.
Title: "The Effects of Retinoic Acid on Immunoglobulin Synthesis by Human Cord Blood Mononuclear Cells" University of Pennsylvania, Philadelphia, Allergy and Immunology Division, March 15, 1991.
Title: "The Effects of Retinoic Acid on Immunoglobulin Synthesis by Human Cord Blood Mononuclear Cells", Hahnemann University, Department of Microbiology and Immunology, Philadelphia, Pennsylvania, March 15, 1991.
Title: "Intravenous immunoglobulin: current guidelines for use.", The Second Jeffrey Modell Immunodeficiency Symposium, Mt Sinai Medical Center, New York, April 17, 1991.
Title: "The Premature Infant as an Immunocompromised Host." at Current Issues In Pediatric Immunology, Arlington, VA, May 17,1991.
Title: "Anatomy of Cellular Elements: Lymphocytes, Monocytes, Macrophages and Neutrophils.", Literature Review for the ABAI Exam, Arlington Heights, April 19, 1991.
Title: "B and T cell differentiation", Department of Dermatology, SUNYAB Dermatology Grand Rounds, Buffalo General Hospital, July 23, 1991.
Title: "New concepts in the use of intravenous gamma globulin", Pediatric Infectious Diseases in the 1990's and beyond, SUNYAB, August 10, 1991.
Title: "Intravenous Immune Serum Globulin". Illinois Society of Allergy and Clinical Immunology. Chicago, IL Sept. 23, 1991.
Title: "New Approaches to Pediatric Asthma". 4th Annual Family Practice Conference, Concord, Ohio, Oct 11, 1991.
Title: "Office Evaluation for Suspected Immunodeficiency", American College of Allergy & Immunology, New York City, Nov. 16, 1991.
Title: "Meet the Professor", American College of Allergy & Immunology, New York City, Nov. 17, 1991.
Title: "The approach to the patient with recurrent infections", Grand Rounds at University of South Alabama, December 19, 1991.
Chairman: "Recent Advances in the Pathophysiology of Primary Immune Deficiencies and Immunoglobulin Therapy in HIV Infection and Autoimmune/Inflammatory Neurological Disorders", Indian Wells, CA January 24-25, 1992.
Title: "B-cell differentiation and antibody diversity" and "Do CD markers on T and B cell have a function?", 15th Annual Update in Clinical Microbiology and Immunology, Park City, UT, February 20-21, 1992.
Title: "Evaluating your patient for immune defects" and "Recent Advances in the Treatment of patients with immune deficiencies", Primary Care for Today's Practitioner, 15th annual Gold Coast Medicine Conference, Good Samaritan Medical Center, West Palm Beach, FL, March 4, 1992.
Title: "The significance of IgG 2 subclass deficiency", Breakfast workshop, American Academy of Allergy and Immunology Meetings, Orlando, FL, March 5, 1992.
Title: The effects of retinoic acid on B lymphocytes immunoglobulin production", Infectious Disease, Erie County Medical Center, March 27, 1992.
Title: "Treatment of Asthma into the year 2000" Medical Grand Rounds at Hamot Medical Center, Erie PA. , April 2, 1992
Title: "Intravenous Immune Globulin: Properties and Mechanisms of Action", New Approaches to Immune Mediated Neurologic Diseases: What is the role of intravenous immune globulin, San Diego, CA, May 2, 1992.
Title: "Immunology of the neonate", 40 Years as Keeper of the inn: A tribute to Milton Markowitz, M.D., University of Connecticut School of Medicine, Farmington, CT, May 29, 1992.
Title: "Intravenous Immune Globulin: Properties and Mechanisms of Action", at "Advances in the Pathogenesis and Treatment of Immune Related Neuromuscular and Demyelinating Diseases: Role of IVIG", Arlington, Virginia. June 5-6, 1992.
Title: "Office evaluation of recurrent infection" The 15th National Conference on Pediatric on Pediatric/Adult Allergy and Clinical Immunology, Children's Hospital of Buffalo, Toronto, Ontario, Canada, July 18, 1992.
Title: "Immune Deficiency Related to Developmental Delay", New England Society of Allergy, Manchester Vermont, October 17-18, 1992.
Title: "Intravenous Immune Serum Globulin: Properties and Mechanisms of Action", New England Society of Allergy, Manchester Vermont, October 17-18, 1992.
Title: "Office evaluation of suspected immunodeficiency" "Office Workup of the Child with Suspected immune deficiency" American College of Allergy and Immunology, Chicago, Illinois, November 15-16, 1992.
Chairman-Symposium: "Recent Advances in Vaccine Development and Delivery, Bone Marrow Transplantation and Adhesion Molecules in the Immune Response", Palm Beach, Florida, January 8-9, 1993.
Seminar: "IgG Subclass Deficiency", American Academy of Allergy and Immunology, Chicago, IL, March 17-17, 1993.
Moderator: "Immunotherapy: The Old and the New", American Academy of Allergy and Immunology, Chicago, IL, March 17-17, 1993.
Course Director: "Immunology Course: Concepts of Immunoregulation and Pathogenesis of Organ-Specific Autoimmune Disease", American Academy of Allergy and Immunology, Chicago, IL, March 17-17, 1993.
Workshop Director: "Controversies and misconceptions about IVIG therapy: Clinical Immunologists Feud over IVIG Therapy", American Academy of Allergy and Immunology, Chicago, IL, March 17-17, 1993.
Title: "Case management of children with recurrent infections", American Academy of Pediatrics, Chicago, IL. March 20, 1993.
Title: "Intravenous Immune Globulin: Properties and Mechanisms of Action" at Pathogenesis and Treatment of Immune-Related Neuromuscular and Demyelinating Diseases: Role of IVIG, The New York Hilton and Towers, Rockefeller Center, The Gramercy Suite, New York, NY, April 24, 1993.
Title: "Chronic sinusitis and recurrent infection in children" Pediatric Grand Rounds, McMaster University Medical Centre, Chedoke-McMaster Hospital, Hamilton, Ontario, Canada, April 29, 1993.
Title: "Intravenous Gammaglobulin: Mechanisms of Action" Allergy/Immunology Rounds, McMaster University Medical Centre, Chedoke-McMaster Hospital, Hamilton, Ontario, Canada, April 30, 1993.
Title: "ADA Deficiency: A disease model for gene therapy", The 16th National Conference on Pediatric/Adult Allergy and Clinical Immunology, July 16-18,1993.
Title: "Changing Concepts in Intravenous Immune Serum Globulin Therapy", at The Second Lloyd V. Crawford, MD Symposium on Allergy and Clinical Immunology, Memphis, Tennessee, September 10-12, 1993.
Title: "Immunologic Reconstitution: An Update", A Symposium on Mechanisms of Allergy, Autumn Allergy Update, American Academy of Allergy and Immunology, New York, NY, October 7-11, 1993.
Title: "Evaluation of Recurrent Infections", at Update in Allergy and Immunology, Nassau County Medical Center, East Meadow, Long Island, NY, October 28, 1993.
Title: "Outpatient evaluation of suspected immunodeficiency", American College of Allergy and Immunology, Atlanta, November 13, 1993.
Title: "Uses of IVIG," Meet-the-Professor breakfast at the American College of Allergy and Immunology, Atlanta, November 15, 1993.
Title: "Bronchodilator Treatment", for New Developments in Bronchodilator for Asthma Lecture Series, National Faculty Conference, Phoenix, AZ, February 18, 1994.
Title: "Mechanisms of Action of IVIG", The 1994 Arbesman Lecture., American Academy of Allergy and Immunology, Anaheim, California, March 5, 1994.
Chairman: "The Role of Superantigens in Disease and Animal Models as Instructional Paradigms of Human Disease: Tuscon, Arizona, April 7-10, 1994.
Title: "Intravenous Immune Globulin: Properties and Mechanisms of Action", for Mechanisms and Immunotherapies in immune-mediated neuorlogical and neuromuscular diseases", American Academy of Neurology, Washington, DC, April 30, 1994.
Title: "Use of Cytokines as Immunomodulating Agents in Disease", The 17th International Conference on Pediatric/Adult Allergy and Clinical Immunology, Toronto Ontario, Canada, July 15, 1994.
Chairman: The 17th International Conference on Pediatric/Adult Allergy and Clinical Immunology, Four Seasons Hotel, Toronto, Ontario, Canada, July 15-17, 1994.
Title: "Update on Asthma Management", SCP Communications, Inc, Rochester, NY October, 4, 1994.
Title: "Uses of IVIG", Meet the Professor breakfast, American College of Allergy and Immunology, San Francisco, CA, November 6, 1994.
Title: "Evaluation of Suspected Immune Deficiency" for American College of Allergy and Immunology, San Francisco, CA, November 8, 1994.
Title: "Asthma Pathogenesis-Is Asthma A T-cell Mediated Disease?" at "New Advances in Asthma Allergy and AIDS 1994" for the Albert Einstein College of Medicine, December 7, 1994.
Title: "Overview of the immune system" at Subspecialty Pediatrics for the Primary Care Physician, The Center for Children, Medical City Dallas Hospital, Dallas, TX, January 28, 1995.
Title: "Traditional management of immunodeficiency"at Subspecialty Pediatrics for the Primary Care Physician, The Center for Children, Medical City Dallas Hospital, Dallas, TX, January 28, 1995.
Title: Co-Moderator of Breakfast Seminar, "IgE Subclass and Antigen Specific Ig Deficiencies" at the American Academy of Allergy and Immunology, New York, NY, February 25,1995.
Title: Co-Moderator of Symposium, "New Insights into tolerance and immunological unresponsiveness" at the American Academy of Allergy and Immunology, New York, NY, February 26,1995
Title: "New Frontiers in the Immunoregulation of Allergic and Autoimmune Diseases" for Health Dimensions, Phoenix, Arizona, March 23-26, 1995.
Title: "Managing Chronic Sinusitis in Children and Adults" at Allergy, Asthma, and Clinical Immunology Conference for Primary Care Physicians, Hurley Medical Center, Flint Michigan, April 8, 1995.
Title: "Intravenous Immune Globulin Properties and Mechanisms of Action" at Mechanisms and Immunotherpies in Immune Mediated Neurological Diseases, Seattle, Washington, May 5, 1995.
Title: "Approach to the patient with Suspected Immunodeficiency", "All You Wanted To Know About Intravenous Gammaglobulin" Albany Medical College, Saratoga Springs, NY, July 27, 1995.
Course Title: "Understanding and Managing Asthma: Update for the Asthma Managed Care Environment", AAAAI, Community Health Plan, Albany, NY, November 8, 1995.
Title: IVIG and Inflammatory myopathies, Grand Rounds, Mobile Alabama, Sponsored by Armour Pharmaceuticals, December 13, 1995.
Title: Intravenous Immune serum globulin (IVIG): What is it and how does it work!" Visiting Professor at Greater Houston Allergy Society meeting, February 6-8, 1996.
Title: "Emerging New Concepts on the Pathogenesis of Asthma" University of Texas Medical Brance in Galveston, TX, February 8, 1996.
Chairman: "New Frontiers in Immunobiology of the Skin and Recent Advances in Cellular Reconstitution and Genetic Engineering", San Diego, California, March 29-30, 1996.
Title: "Update on Pediatric Asthma Management", Little Falls Hospital, LIttle Falls, NY April 9, 1996.
Title: "Evaluation of the patient with recurrent infection ", Fort Wayne Medical Institute, Fort Wayne, IN, May 4, 1996.
Title: "The Child with Recurrent Infections", Pennsylvania Allergy and Asthma Association Meeting, 48th Annual Meeting, Hershey PA, June 29, 1996.
Chairperson: "IVIG in Autoimmune and Inflammatory Diseases" Session, at Interlakens Fourth International Symposium on IVIG, Interlaken, Switzerland, June 11-13, 1996
Organizer and Speaker--Titles: "The Role of Nitric Oxide in Asthma", "Approach to the Patient with Adverse Drug Reactions: at 19th International Conference on Pediatric Adult Allergy and Immunology, Toronto, Ontario, Canada, July 18-21, 1996.
Title: "Effects of retinoic acid on IL-2 in RNA and IL-2 receptors" Collegium International Allergologicum 21st Symposium, Salzburg, Austria, September 6-11, 1996
Title: "Recent Advances in the Treatment of Immunodeficiency Disorders", Clinical Cutaneous Allergy and Immunology, AAAAI/AAD, New York, NY, October 4, 1996.
Title: "Principles of Management of Primary Immune Deficiencies" at Immunoregulation and Therapy of Immunologic Diseases, Naples FL, October 6, 1996.
Title: "Prophylaxis of Sinusitis", New England Allergy Society, Portland, ME, October 19, 1996.
Title: "Evaluation of suspected Immune deficiency" workshop, American College of Allergy, Asthma and Immunology, Boston, MA, November 9, 1996.
Title: "Emerging concepts in intravenous immunoglobulin (IVIG) therapy", Medical Grand Rounds, Shadyside Hospital, Pittsburgh PA, November 21, 1996.
Title: "Mechanisms and applications for use of IVIG", Medical Grand Rounds, University of Connecticut Health Center School of Medicine, Farmington, CT, February 12, 1997.
Title: "Immunodeficiency and Autoimmunity", at Human Dysfunction workshop, Co-Moderator, American Academy of Allergy, Asthma and Immunology, February 24, 1997.
Title: "Treatment of Asthma" and "Evaluation of the Child with Recurrent Infections" Beijing Children's Hospital, Beijing, P.R. China, April 9, 1997.
Title: "Treatment of Asthma", Children's Hospital of Shanghai, Shanghai, P.R. China, April 14-15, 1997.
Title: "Vitamin A and Beyond: From Measles to Immune Modulation", Eleventh Annual Tri-Service Infectious Disease Conference, Key West, FL, Sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, April 30, 1997.
Organizer and Speaker --Titles: "The Role of Programmed Cell Death in Health and Disease": at 20 th International Conference on Pediatric/Adult Allergy and Clinical Immunology, Toronto, Ontario, Canada, August 1-3, 1997.
Title: "New Insights in Managing Pediatric Asthma", Pediatric Department Conference, Mount St. Mary's Hospital, Lewiston, NY, Sponsored by Merck Pharmaceutical (Respiratory Diseases, U.S. Human Health)November 13, 1997.
Title: "Mechanisms and applications for use of IVIG", Denver Allergy Society, Feb. 17, 1998.
Title: " Modulation of immune responses by retinoids" , National Jewish Hospital, Department of Medicine, Feb. 18, 1998.
Title: "Mechanisms of action of IVIG in autoimmune and inflammatory diseases", Consultant for Expert Panel on IVIG, NIAID, NIH. Feb 26, 1998.
Title: " Diagnosis and treatment of the sneezing and congested patient - is it allergies, sinusitis, or just a cold. April 9, 1998.
Organizer and Speaker -- Titles: "Mechanism of Action of IVIG" at 21 st International Conference on Pediatric/Adult Allergy and Clinical Immunology, Toronto, Ontario, Canada, July 24-26, 1998.
Title: "Use of IVIG - New preparations, new indications, new controversies", American College of Allergy, Asthma and Immunology, Philadelphia, PA, November 7, 1998.
Title: "Role of Leukotrienes in the Treatment of Childhood Asthma, Buffalo Pediatric Society, November 19, 1998.
Title: "Issues on the Safety and Availability of IGIV", symposium "Safety and Availability of IGIV", Las Vegas, Nevada, December 7, 1998.
Title: "The Future of Our Specialty", Virginia Allergy Society, February 6, 1999
Title: "Immune Deficiency" at 55 th Annual Meeting of American Academy of Allergy, Asthma and Immunology, Orlando, Florida, February 26, 1999.
Title: Workshop, "Uses and Abuses of IVIG in Immune Deficiency and Autoimmune Diseases", at the American Academy of Allergy, Asthma and Immunology, Orlando, Florida, February 27, 1999.
131. Title: "New Approaches in the Therapy of Allergic Diseases", Connecticut Allergy Society, April 22, 1999.
132. Title: "The Effects of Retinoids on TNB-Cell Function", Department of Immunology, Mount Sinai Medical Center, New York, April 23, 1999.
133. Title: " The paradigm of the lymphocytes TH1 and TH2 in asthma " at IX International Meeting of Asthma, Allergy and Immunology, May 27-29, 1999, Buenos Aires, Argentina.
Title: " New knowledge about the pathogenesis of immunodeficiencies " at International Meeting of Asthma, Allergy and Immunology, May 27-29, 1999, Buenos Aires, Argentina.
Title: " What is new in the treatment of primary immune deficiencies" at IX International Meeting of Asthma, Allergy and Immunology, May 27-29, 1999, Buenos Aires, Argentina.
Title: "Allergic Rhinitis & Sinusitis", Treatment of Seasonal Allergies Pfizer Pharmaceuticals Speakers Program, June 5, 1999, Buffalo, New York.
Title: Workshop, "Asthma, New Guidelines and Controversies", at the Asthma, Allergy & Immunology Fingerlakes Medical Conference, June 12, 1999, Ithica, New York.
Title: "New Approaches to the Treatment of Allergic Diseases", Grand Rounds,Department of Pediatrics, Children's Hospital of Buffalo, June 25, 1999, Buffalo, New York.
Title: "Pediatric Immunodeficiency Diseases: Lessons Learned from Experiments of Nature" at The Association of Medical Laboratory Immunologists Annual Meeting, July 9, 1999, Bethesda, Maryland.
Title: "Recent & Future Developments in the Diagnosis and Treatment of Primary Immune Deficiencies" at 5 th Annual Summer Conference: Allergy, Asthma and Immunology at the Threshold of the 21 st Century, July 29-30, 1999, Saratoga Springs, New York.
Organizer and Speaker -- Title: "New Approaches to Allergy Immunotherapy: DNA Vaccine" at 22 nd International Conference on Pediatric/Adult Allergy and Clinical Immunology, Toronto, Ontario, Canada, July 16-18, 1999.
Title: "Role of Retinoids (Vitamin A) in Modulating the Immune Response", University of California, Irvine, Division of Basic and Clinical Immunology, Department of Medicine, November 5, 1999.
Title: Co-Moderator of Symposium, "Chronic Sinusitis and Nasal Polyposis" at 56 th Annual Meeting of American Academy of Allergy, Asthma and Immunology, San Diego, California, March 5, 2000.
Title: "Immunodeficiency: Clinical Aspects/Genetics/Approach to Therapy" at 56 th Annual Meeting of American Academy of Allergy, Asthma and Immunology, San Diego, California, March 7, 2000.
Title: Breakfast Seminar "Appropriate Uses and Monitoring of Intravenous Gamma Globulin Therapy" at 56 th Annual Meeting of American Academy of Allergy, Asthma and Immunology, San Diego, California, March 8, 2000
Title: "Treatment of Autoimmune Diseases with Intravenous Immune Globulin: Mechanisms of Action", Grand Rounds, University of Tennessee, Division of Allergy and Immunology, Department of Medicine, June 7, 2000.
Title: "Office Evaluation of Recurrent Infections", Florida Allergy Asthma and Immunology Society Annual Meeting, Allergy, Asthma and Immunology into the Next Millennium, Lake Buena Vista, Florida, June 9 - 11, 2000.
Title: "New Insights into the Pathogenesis of B-Cell Immune Deficiencies", Florida Allergy Asthma and Immunology Society Annual Meeting, Allergy, Asthma and Immunology into the Next Millennium, Lake Buena Vista, Florida, June 9 - 11, 2000.
Title: "New Advances in Asthma", Grand Rounds, Catholic Health System, Sisters of Charity Hospital, Buffalo, New York, June 28, 2000.
Organizer and Speaker -- Title: "Opportunistic Infections and Immune Deficiencies" at 23 rd International Conference on Pediatric/Adult Allergy and Clinical Immunology, Toronto, Ontario, Canada, July 21-23, 2000.
Title: "Office Evaluation of Immune System", Family Practice Lecture Series, Catholic Health System, Sisters of Charity Hospital, Buffalo, New York, August 10, 2000.
Title: "Future Directions in the Treatment of Allergic Diseases with Immunotherapy", SUNY Syracuse, School of Medicine, Department of Medicine, Grand Rounds, September 7, 2000.
Title: "Asthma Control: New York's Biggest Health Challenge", Erie County Medical Society and The Medical, Educational and Scientific Foundation, a subsidiary of the Medical Society of the State of New York, Buffalo, New York, September 11, 2000.
Title: "Current Perspectives on the Use of Intravenous Immune Globulin (IVIG), Virginia Society of Health-System Pharmacists (VSHP) Region II Program of Continuing Education for Pharmacists and Technicians, September 20, 2000.
Title: "Vitamin A: Effects on Immunization and Risk of Infection", 10 th Anniversary Pastor Lectureship, Women's and Children's Health Research Foundation, Children's Hospital of Buffalo, NY, September 22, 2000.
Title: "Opportunistic Infections and Immune Deficiency", at Buffalo 2000, Division of Allergy Immunology Rheumatology, State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, September 23, 2000.
Title: "Introduction to Pulmicort Respules", Tonawanda Pediatrics, Tonawanda, NY, October 18, 2000.
Title: "New Approaches in the Treatment of Allergy Diseases", Medical Grand Rounds, Long Island Jewish Medical Center, New York , October 27, 2000
"The ABCs of Leukocyte Trafficking and Defects Leading to Recurrent Infection", John C. Selner Lecture, American College of Allergy, Asthma and Immunology, Seattle, WA, November 7, 2000.
Workshop Title: "How to Teach a Rotating Resident", American College of Allergy, Asthma and Immunology, Philadelphia, PA, November 7, 2000.
Lecture Title: "Therapeutics", Compass Pilot Program, American Academy of Allergy, Asthma and Immunology, Washington, DC, November 15, 2000.
Title: "Quality and Safety of Plasma Products", Quality & Safety Speakers Bureau Meeting, Tarry Town, NY, January 18, 2001.
Title: "Initiating Controller Therapy in Asthma", Pediatric Service Educational Program , Olean General Hospital, March 9, 2001, Olean, New York.
Presenter: "Appropriate Uses and Monitoring of Intravenous Gamma Globulin Therapy", American Academy of Allergy and Immunology 57 th Annual Meeting, New Orleans, Louisiana, March 17, 2001.
Moderator: Antibody Deficiency and IVIG", American Academy of Allergy and Immunology 57 th Annual Meeting, New Orleans, Louisiana, March 17, 2001.
Presenter: "Mechanisms of Action of IVIG", American Academy of Allergy and Immunology 57 th Annual Meeting, New Orleans, Louisiana, March 19, 2001.
Title: "Compass: New Directions in the Treatment of Allergic Conjunctivitis and Related Disorders", Kaiser Foundation Health Plan of the Mid-Atlantic States, Inc.,Vienna, Virginia, May 16, 2001.
Title: "T-Cell Disorders", Infections in the Immunocompromised Patient, Roswell Park Cancer Institute, Niagara on the Lake, Ontario, Canada, June 23, 2001.
Organizer and Speaker -- Title: "Alternate Approaches to Therapy of Allergic Disease" at 24 th International Conference on Pediatric/Adult Allergy and Clinical Immunology, Toronto, Ontario, Canada, July 20-22, 2001.
Title: "Problem-Based Learning: A Case Study Workshop", International Meeting & Science Inc. Faculty Meeting: Asthma and Allergic Rhinitis: Connecting Common Pathways and Treatment, July 27-29, 2001, Ottawa, Ontario, Canada.
Title: "The Role of Leukotrienes in Pediatric Asthma".Syracuse, NY, August 14, 2001.
Title: "New Directions in the Treatment of Allergic Conjunctivitis and Related Disorders", Albany Compass Program, American Academy of Allergy, Asthma and Immunology, Albany, NY, September 19, 2001.
Title: "New Directions in the Treatment of Allergic Conjunctivitis and Related Disorders", American Academy of Allergy, Asthma and Immunology, Massachusettes, November 1, 2001.
Title: "Current Treatments in the Management of Pediatric Asthma", Buffalo, NY, March 20, 2002.
Title: "Role of Nasal Steroids as They Relate to the Upper and Lower Airway", Buffalo, NY, March 25, 2002.
Title: "Appropriate Uses and Monitoring of Intravenous Gamma Globulin Therapy", American Academy of Allergy and Immunology 58 th Annual Meeting, New York, New York, March 3, 2002.
Title: "IVIG: Product Selection and Administration", American Academy of Allergy and Immunology 58 th Annual Meeting, New York, New York, March 3, 2002.
Title: "Administration of IVIG and Treatment of Adverse Effects", American Academy of Allergy and Immunology 58 th Annual Meeting, New York, New York, March 5, 2002.
Title: "Asthma : Immunotherapy", City-Wide Grand Rounds, Department of Medicine, School of Medicine and Biomedical Sciences, University at Buffalo, April 18, 2002, Buffalo, New York.
Organizer and Speaker -- Title: "Risk Factors for the Development of Allergic Disease" at 25 th International Conference on Pediatric/Adult Allergy and Clinical Immunology, Toronto, Ontario, Canada, July 19-21, 2002.
Presenter: "Risk Factors in the Development of Allergic Diseases", Integrative Medicine 2002, Women and Children's Health Research Foundation, Children's Hospital of Buffalo/Kaleida Health, September 13, 2002.
Title: "IGIV Therapy and Other Treatment Options for Primary Immune Deficiency Diseases", Immune Deficiency Foundation Operation Outreach Educational Meeting, Rochester, NY, November 2, 2002.
Title: "New Approaches for the Diagnosis and Management of Asthma" , Medical Education Program, Syracuse, NY, September 12, 2002. Title: "Asthma - New Treatments", Buffalo Pediatric Society, Buffalo, NY, September 24, 2002.
Lecture Title: "Evaluation of the Patient with Recurrent Infections", Visiting Professor, China, October 17-21, 2002.
Lecture Title: " New Concepts in Treatment of Asthma", Visiting Professor, China, October 17-21, 2002.
Title: "Risk Factors in the Development of Allergic Diseases", University of South Florida College of Medicine/All Children's Hospital Pediatric Grand Rounds, St. Petersberg, Florida, November 21-22, 2002.
Research Conference: "Vitamin A and Modulation of the Immune System", University of South Florida College of Medicine/All Children's Hospital, St. Petersberg, Florida, November 21-22, 2002.
Title: "Acquired Immune Deficiencies Including AIDS, Congenital Immune Deficiencies and Graft vs. Host Reaction/Bone Marrow Transplantation", Certification Course for Allergy Boards, March 22, 2003.
Title: "Approach to the Patient with Recurrent Infection" Rush Medical Center, Pediatric Grand Rounds, Chicago, IL, March 26, 2003.
Seminar Title: "Uses and Abuses of IVIG Therapy", Rush Medical Center, Chicago, IL, March 26, 2003.
Recertification Lectures for Allergy/Immunology Boards, Dallas, TX, April 5, 2003
Title: "Appropriate and Non-Label Uses of Intravenous Gamma Globulin Therapy", 60 th Annual Meeting of American Academy of Allergy, Asthma and Immunology, Denver, CO, March 9, 2003.
Title: "IVIG Therapy in the New Millennium", Illinois Council of Health-System Pharmacists, St. Louis , Missouri, April 25, 2003.
Title: "Stepwise Evaluation of Suspected Immune Deficiencies", Recognition of Primary Immune Deficiencies, - If You Don't Look, You Won't See..You Will Never Know, University Hospitals of Cleveland Health System, Rainbow Babies and Children's Hospital, Cleveland, Ohio, June 14, 2003.
Title: "Immune Globulin Therapy Subcutaneous Administration" Immune Deficiency Foundation Second National Conference in Baltimore, MD, June 19-21, 2003.
Title: "Asthma Management: Following the Guidelines", Grand Rounds , Catholic Health System, Sisters of Charity Hospital, Buffalo, NY, June 25, 2003.
Title: "Clinical Immunodeficiency Syndromes ", World Allergy Organization, IAACI (WAO) Congress - XVIII ICACI, Vancouver, British Columbia, Canada, September 8, 2003.
Title: "Are All IVIGs the Same?", Nebraska Allergy Society, Omaha, Nebraska, October 23, 2003.
Title: "Effects of Retinoids on the Immune System", Grand Rounds, Creighton University, Omaha, Nebraska, October 24, 2003.
Title: "Evaluation of Patients with Recurrent Infection", Visiting Professor Lecture to fellows, Creighton University, Omaha, Nebraska, October 24, 2003.
Title: "Evaluation of the patient with recurrent infections", Grand Rounds, Michigan State University Kalamazoo Center for Medical Studies, Kalamazoo, Michigan, January 30, 2004.
Title: "The Effects of Retinoic Acid on Immune Responses", Boston Children's Hospital, Boston, MA, March 8, 2004.
Title: "The Role of the Eosinophil in Asthma", Brigham and Women's Hospital, Boston, MA, March 9, 2004.
Title: Breakfast Seminar "Clinical Use of IVIG" at 60 th Annual Meeting of American Academy of Allergy, Asthma and Immunology, San Francisco, California, March 23, 2004.
Title: "Optimizing Outcomes with IVIG Therapy", Allergy Update 2004 21 st Annual Symposium, Allergy Asthma & Immunology Society of Ontario, Canada, April 17, 2004.
Title: "Chronic Recurrent Infections: When to Evaluate and When to Treat", Allergy and Clinical Immunology 62 nd Annual Course, Departments of Medicine, Pediatrics and Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, April 23, 2004.
Title: "The Goal is Control: Update on Asthma Management", Kaleida Health Pediatrics, Buffalo, NY, June 11, 2004.
Title: "Evaluation of the Patient with Recurrent Infection", Pennsylvania Allergy & Asthma Association, 56 th Annual Meeting, Harrisburg, PA, June 26, 2004.
Title: "Uses of IVIG", Pennsylvania Allergy & Asthma Association, 56 th Annual Meeting, Harrisburg, PA, June 26, 2004.
Teaching Faculty: "Chronic Recurrent Infections: When to Evaluate and When to Treat", from the University of Minnesota's 62 nd Annual Course on Allergy and Clinical Immunology, Audio-Digest Otolaryngology, Volume 37, Issue 15, August 7, 2004.
Title: "Evaluation of the Patient with Recurrent Infections", Immunology in the Office Setting, Joint Sponsorship of the American Thoracic Society and the American Lung Association of New York State/New York State Thoracic Society, Syracuse, NY, October 9, 2004.
Title: "Humoral Immune Deficiency Disorders: State of the Art", 2004 Canadian Society of Allergy and Clinical Immunology 2004 Annual Scientific Meeting, Ottawa, Ontario, October 22, 2004.
Title: "Evaluation of the Patient with Recurrent Infections", Pediatric Grand Rounds, Department of Pediatrics, The University of Texas Medical Branch, Galveston, Texas, January 21, 2005.
Title: "Mechanisms of Action of IVIG", Department of Medicine, Allergy/Immunology Division, The University of Texas Medical Branch, Galveston, Texas, January 20, 2005.